819 536

Cited 0 times in

뇌종양 환아에서 성장호르몬 치료 후 뇌종양 재발증가에 관한 연구

Other Titles
 Recurrence of Brain Tumors in Patients Treated with Growth Hormone 
 김덕희  ;  채현욱  ;  권미영  ;  김호성 
 Journal of Korean Society of Pediatric Endocrinology (대한소아내분비학회지), Vol.12(2) : 99-103, 2007 
Journal Title
Journal of Korean Society of Pediatric Endocrinology(대한소아내분비학회지)
Issue Date
Brain tumor recurrence ; Growth hormone ; Craniopharyngioma ; Medulloblastoma ; Germinoma
Growth hormone (GH) has been used successfully in the treatment of short stature secondary to GH deficiency in survivors of childhood brain tumors. There has been concerned that GH might increase the risk of tumor recurrence in spite of improvement of growth.

Data for tumor recurrence from 1997 to 2006 were analysed retrospectively in 56 patients with craniopharyngioma, 78 patients with medulloblastomas, 14 patients with germinomas and 139 patients with astrocytomas or gliomas after GH treatment. Serum insulin-like growth factor (IGF)-1 and IGF binding protein (IGFBP)-3 were measured.

57 GH deficient and growth retarded patients (17.4%) were treated with recombinant human GH and followed up 60 months after starting GH treatment. 6 patients (10.5%) (5 craniopharyngioma, 1 germinoma) were recurred among patients with GH therapy, but 17 patients (5.2%) were recurred among patients with non GH therapy. Tumor recurrence in GH treated group was not higher than in non GH treated group. There was no significant change in serum IGF-1, IGFBP-3 level and IGF-1/IGFBP-3 ratio.

Tumor recurrence rates in surviving patients with brain tumors receiving GH treatment do not appear to be increased compared with non GH treatment. However, longer follow-up regarding recurrences and secondary neoplasms remains to be essential.
Files in This Item:
T200701519.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Duk Hee(김덕희)
Kim, Ho Seong(김호성) ORCID logo https://orcid.org/0000-0003-1135-099X
Chae, Hyun Wook(채현욱) ORCID logo https://orcid.org/0000-0001-5016-8539
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.